AIMT - Aimmune Therapeutics, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD
Earnings EstimateCurrent Qtr. (Sep 2019)Next Qtr. (Dec 2019)Current Year (2019)Next Year (2020)
No. of Analysts10101010
Avg. Estimate-1.04-1.08-4.02-3.59
Low Estimate-1.12-1.27-4.26-4.11
High Estimate-0.88-0.92-3.68-2.75
Year Ago EPS-0.89-0.95-3.67-4.02
Revenue EstimateCurrent Qtr. (Sep 2019)Next Qtr. (Dec 2019)Current Year (2019)Next Year (2020)
No. of Analysts99910
Avg. EstimateN/AN/AN/A55.17M
Low EstimateN/AN/AN/A35M
High EstimateN/AN/AN/A74.55M
Year Ago SalesN/AN/AN/AN/A
Sales Growth (year/est)N/AN/AN/AN/A
Earnings History9/29/201812/30/20183/30/20196/29/2019
EPS Est.-0.9-0.91-0.97-0.94
EPS Actual-0.89-0.95-0.87-1.01
Difference0.01-0.040.1-0.07
Surprise %1.10%-4.40%10.30%-7.40%
EPS TrendCurrent Qtr. (Sep 2019)Next Qtr. (Dec 2019)Current Year (2019)Next Year (2020)
Current Estimate-1.04-1.08-4.02-3.59
7 Days Ago-1.04-1.08-4.02-3.59
30 Days Ago-1.04-1.09-4.02-3.52
60 Days Ago-1.04-1.09-4.02-3.43
90 Days Ago-0.98-1.03-3.83-3.15
EPS RevisionsCurrent Qtr. (Sep 2019)Next Qtr. (Dec 2019)Current Year (2019)Next Year (2020)
Up Last 7 DaysN/AN/AN/AN/A
Up Last 30 DaysN/A111
Down Last 7 DaysN/AN/AN/AN/A
Down Last 30 DaysN/AN/AN/AN/A
Growth EstimatesAIMTIndustrySectorS&P 500
Current Qtr.-16.90%N/AN/A-0.02
Next Qtr.-13.70%N/AN/A0.07
Current Year-9.50%N/AN/A-0.02
Next Year10.70%N/AN/A0.14
Next 5 Years (per annum)34.60%N/AN/A0.07
Past 5 Years (per annum)N/AN/AN/AN/A